These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 21428211)
1. Silencing of Bmi-1 gene by RNA interference enhances sensitivity to doxorubicin in breast cancer cells. Wu X; Liu X; Sengupta J; Bu Y; Yi F; Wang C; Shi Y; Zhu Y; Jiao Q; Song F Indian J Exp Biol; 2011 Feb; 49(2):105-12. PubMed ID: 21428211 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of the Bmi-1 oncogene inhibits cell proliferation and induces cell apoptosis and is involved in the decrease of Akt phosphorylation in the human breast carcinoma cell line MCF-7. Xu Z; Liu H; Lv X; Liu Y; Li S; Li H Oncol Rep; 2011 Feb; 25(2):409-18. PubMed ID: 21152871 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells. Qin L; Zhang X; Zhang L; Feng Y; Weng GX; Li MZ; Kong QL; Qian CN; Zeng YX; Zeng MS; Liao DF; Song LB Biochem Biophys Res Commun; 2008 Jul; 371(3):531-5. PubMed ID: 18452707 [TBL] [Abstract][Full Text] [Related]
4. Human sodium iodide symporter added to multidrug resistance 1 small hairpin RNA in a single gene construct enhances the therapeutic effects of radioiodine in a nude mouse model of multidrug resistant colon cancer. Jeon YH; Ahn SJ; Lee YJ; Lee YL; Lee SW; Park SY; Kim IS; Ahn BC; Ha JH; Lee J Cancer Biother Radiopharm; 2010 Dec; 25(6):671-9. PubMed ID: 21204761 [TBL] [Abstract][Full Text] [Related]
5. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer. Hu Y; Xu K; Yagüe E Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794 [TBL] [Abstract][Full Text] [Related]
6. Effect of siRNA-mediated silencing of Bmi-1 gene expression on HeLa cells. Jiang Y; Su B; Meng X; Liu C; Liu B; Liu D; Fan Y; Yang H Cancer Sci; 2010 Feb; 101(2):379-86. PubMed ID: 19930157 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance. Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554 [TBL] [Abstract][Full Text] [Related]
8. Reversal of doxorubicin resistance by guggulsterone of Commiphora mukul in vivo. Xu HB; Shen ZL; Fu J; Xu LZ Phytomedicine; 2014 Sep; 21(11):1221-9. PubMed ID: 25172783 [TBL] [Abstract][Full Text] [Related]
9. Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells. Liu ZG; Liu L; Xu LH; Yi W; Tao YL; Tu ZW; Li MZ; Zeng MS; Xia YF Oncol Rep; 2012 Apr; 27(4):1116-22. PubMed ID: 22209830 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma. Song X; Wang JB; Yin DL; Yang HY; Liu LX; Jiang HC Chin Med J (Engl); 2009 Nov; 122(21):2636-42. PubMed ID: 19951584 [TBL] [Abstract][Full Text] [Related]
11. Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells. Yin T; Wei H; Leng Z; Yang Z; Gou S; Wu H; Zhao G; Hu X; Wang C Chemotherapy; 2011; 57(6):488-96. PubMed ID: 22248802 [TBL] [Abstract][Full Text] [Related]
12. Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells. Guo WJ; Zeng MS; Yadav A; Song LB; Guo BH; Band V; Dimri GP Cancer Res; 2007 Jun; 67(11):5083-9. PubMed ID: 17545584 [TBL] [Abstract][Full Text] [Related]
13. Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy. Aliabadi HM; Maranchuk R; Kucharski C; Mahdipoor P; Hugh J; Uludağ H J Control Release; 2013 Nov; 172(1):219-228. PubMed ID: 23994345 [TBL] [Abstract][Full Text] [Related]
14. Silencing Bmi-1 expression by RNA interference suppresses the growth of laryngeal carcinoma cells. Yao XB; Wang XX; Liu H; Zhang SQ; Zhu HL Int J Mol Med; 2013 May; 31(5):1262-72. PubMed ID: 23525303 [TBL] [Abstract][Full Text] [Related]
15. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells. Prados J; Melguizo C; Rama AR; Ortiz R; Segura A; Boulaiz H; Vélez C; Caba O; Ramos JL; Aránega A Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430 [TBL] [Abstract][Full Text] [Related]
16. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo. Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676 [TBL] [Abstract][Full Text] [Related]
17. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707 [TBL] [Abstract][Full Text] [Related]
18. shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis. Meng X; Wang Y; Zheng X; Liu C; Su B; Nie H; Zhao B; Zhao X; Yang H Lung Cancer; 2012 Jul; 77(1):24-30. PubMed ID: 22420951 [TBL] [Abstract][Full Text] [Related]
19. CIAPIN1 gene silencing enhances chemosensitivity in a drug-resistant animal model in vivo. Wang XM; Gao SJ; Guo XF; Sun WJ; Yan ZQ; Wang WX; Xu YQ; Lu D Braz J Med Biol Res; 2014 Apr; 47(4):273-8. PubMed ID: 24676475 [TBL] [Abstract][Full Text] [Related]
20. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]